The collaboration further expands Qiagen’s testing portfolio for the early detection of diseases and individualised treatment of patients thereby strengthening Qiagen’s molecular diagnostics offering for applications in prevention
Mr Madsen joined Novavax in 2008 as director of BioProcess Development with responsibility for development of Novavax’s seasonal and pandemic influenza vaccines for clinical testing. Earlier, he was
The regulator has also advised manufacturers of liquid Vitamin D supplements that droppers accompanying these products should be clearly and accurately marked for 400 international units (IU). In
Axxess Pharma claimed that it would also be the first company to introduce a unique herbal, non-alcohol based antiseptic hand wash and disinfectant to the Canadian market. Axxess
The BD Bactec MGIT 320 system is half the physical size of the BD Bactec MGIT 960 system, a fully automated system for mycobacterial liquid culture and susceptibility
The committee’s vote followed a review of data from the Ulipristal Acetate preclinical and clinical development program, involving more than 4000 women from the US and Europe. The
The double-blind pivotal study is expected to compare the efficacy and safety of once-daily oral administration of 200 mg of Torezolid Phosphate over six days of treatment to
Titan Pharmaceuticals is the assignee of this patent which claims a method for treating opiate addiction with a subcutaneously implanted device comprising buprenorphine and ethylene vinyl acetate, a
The trial was conducted by Roche and Genentech, Curis’ collaborator and a wholly owned member of the Roche Group. GDC-0449 is being developed by Roche and Genentech under
Velcade (bortezomib) is a medicine used to treat the blood based cancer known as multiple myeloma. It contains an active substance called Bortezomib and is the first in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.